Skip to content

Ketamine: all studies

Page 127 of 449: studies 1,261 to 1,270 of 4,483, newest first. Back to the ketamine overview

Research

Association Between Low-Dose Ketamine After Periacetabular and/or Femoral Osteotomy and Postoperative Opioid Requirements.

Orthopaedic journal of sports medicine August 1, 2024 Nicholas G Girardi, Sean Malin, Christopher Zielenski et al.

Previous studies have sought to determine the effect of inpatient ketamine therapy on postoperative pain in a variety of surgical specialties. To determine the effects of postoperative ketamine analgesia after periacetabular osteotomy (PAO) and/or derotational femoral osteotomy (DFO) on opioid requirements, pain, and discharge time. Cohort study; Level of evidence, 3. Prospective data were...

DOI: 10.1177/23259671241257260 (opens in new tab) Full text (opens in new tab) Morphine milligram equivalent Opioids Periacetabular osteotomy Postoperative pain +5

"K Cramps," Recurrent Abdominal Pain in a Patient with Chronic Ketamine Use: A Case Report.

Clinical Practice and Cases in Emergency Medicine August 1, 2024 Tucker Avra, Jesus Torres, Kumar Felipe Vasudevan et al. 2 citations

Medical and nonmedical ketamine use is increasing in the United States. This will likely lead to an increase in emergency department (ED) visits in individuals experiencing associated side effects. Physicians will need to be able to effectively recognize and manage ketamine-related complications. A 31-year-old male with a three-year history of inhalational, intramuscular, and intravenous...

DOI: 10.5811/cpcem.19431 (opens in new tab) Full text (opens in new tab) Ketamine abuse Chronic pain Drug-induced illness Emergency medicine +1

Evaluation of the Use of Ketamine in Prehospital Seizure Management: A Retrospective Review of the ESO Database.

Prehospital emergency care July 31, 2024 Joseph Daniel Finney, Paul D Schuler, James R Rudloff et al. 4 citations

Benzodiazepines are the primary antiseizure medication used by Emergency Medical Services (EMS) for seizures. Available literature in the United States and internationally shows 30% to 40% of seizures do not terminate with benzodiazepines called benzodiazepine refractory status epilepticus (BRSE). Ketamine is a potential treatment for BRSE due to its unique pharmacology. However, its...

DOI: 10.1080/10903127.2024.2382367 (opens in new tab) Full text (opens in new tab) Seizure treatment Ketamine therapy Emergency medicine Drug-resistant epilepsy +1

The N-methyl-d-aspartate receptor hypothesis of ketamine's antidepressant action: evidence and controversies.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences July 29, 2024 Yihao Jiang, Yiyan Dong, Hailan Hu

Substantial clinical evidence has unravelled the superior antidepressant efficacy of ketamine: in comparison to traditional antidepressants targeting the monoamine systems, ketamine, as an N-methyl-d-aspartate receptor (NMDAR) antagonist, acts much faster and more potently. Surrounding the antidepressant mechanisms of ketamine, there is ample evidence supporting an NMDAR-antagonism-based...

DOI: 10.1098/rstb.2023.0225 (opens in new tab) Full text (opens in new tab) Nmdar hypothesis Nmdar inhibitors Antidepressant efficacy Depression treatment +4

Ketamine in fibromyalgia: a systematic review.

Advances in rheumatology (London, England) July 29, 2024 Jozélio Freire de Carvalho, Eduardo Pondé de Sena 8 citations

Fibromyalgia (FM) subjects are treated with antidepressant agents; in most cases, these drugs lose efficacy or have adverse effects. Ketamine is an anesthetic drug used in FM in some studies. This article aims to systematically review the safety and efficacy of ketamine in fibromyalgia (FM) patients. We systematically searched articles on FM and ketamine published at Pubmed from 1966 to 2021....

DOI: 10.1186/s42358-024-00393-9 (opens in new tab) Full text (opens in new tab) Depression Anesthetics Ketamine therapy Chronic pain treatment +3

Basic aspects of ketamine therapy for treatment-resistant depression - a review paper

Quality in Sport July 28, 2024 Weronika Szafrańska, Dominika Poborowska, Tomasz Gańko et al.

Introduction and purpose: Major depressive disorder (MDD) is the most common psychiatric illness, affecting millions of people worldwide. The first line of pharmacological treatment is usually monoamine reuptake inhibitors. Up to 60% of cases, may be drug-resistant patients, prompting researchers to research substances other than conventional. 1 The purpose of this article was to review recent...

High-order brain interactions in ketamine during rest and task: a double-blinded cross-over design using portable EEG on male participants.

Translational Psychiatry July 27, 2024 Rubén Herzog, Florentine Marie Barbey, Md Nurul Islam et al. 13 citations

Ketamine is a dissociative anesthetic that induces a shift in global consciousness states and related brain dynamics. Portable low-density EEG systems could be used to monitor these effects. However, previous evidence is almost null and lacks adequate methods to address global dynamics with a small number of electrodes. This study delves into brain high-order interactions (HOI) to explore the...

Transient peripheral blood transcriptomic response to ketamine treatment in children with ADNP syndrome.

Translational Psychiatry July 25, 2024 Ariela S. Buxbaum Grice, Laura G Sloofman, Tess Levy et al. 3 citations

Activity-dependent neuroprotective protein (ADNP) syndrome is a rare neurodevelopmental disorder resulting in intellectual disability, developmental delay and autism spectrum disorder (ASD) and is due to mutations in the ADNP gene. Ketamine treatment has emerged as a promising therapeutic option for ADNP syndrome, showing safety and apparent behavioral improvements in a first open label study....

A randomized controlled pilot study of daily intravenous ketamine over three days for treatment-resistant depression.

BMC Psychiatry July 18, 2024 Keerati Pattanaseri, Juthawadee Lortrakul, Kankamol Jaisin et al. 11 citations

Studies have confirmed the rapid antidepressant action of ketamine in depressive episodes. Nevertheless, a standardized procedure for the delivery of ketamine infusion in individuals suffering from treatment-resistant depression, particularly in terms of infusion frequency and total dosage, remains undetermined. In addition, an efficacious ketamine regimen for persistent pain management...

DOI: 10.1186/s12888-024-05951-5 (opens in new tab) Full text (opens in new tab) Response Tolerability Depression treatment Ketamine therapy +3

Effect of ketamine enantiomers and maternal deprivation on depressive-like behavior and plasma concentration of BDNF in rats

Research, Society and Development July 15, 2024 G. Beanes, Beatriz A Carneiro, G. Marques et al.

Background: Low doses of different ketamine enantiomers have demonstrated rapid behavioural and biological actions in animals with depressive-like behavior. However, some authors report different effects depending on model of depression and ketamine isomer used. Objective: Our primary aim was to evaluate the effect of ketamine enantiomers on depressive-like behavior, anhedonic-like behavior and...